| Followers | 131 |
| Posts | 15004 |
| Boards Moderated | 0 |
| Alias Born | 06/04/2018 |
Saturday, November 07, 2020 3:45:23 PM
BREAKING NEWS: $DXCM Why Is No One Talking About DexCom Stock?
Glucose monitor maker DexCom (NASDAQ: DXCM) has had a rough month. After a Wall Street analyst downgraded the stock Oct. 2 and sharply trimmed its price target, the price fell over the next 30 days, with the majority of the downward movement taking place in the last week of Octo...
Got this from DXCM - Why Is No One Talking About DexCom Stock?
Glucose monitor maker DexCom (NASDAQ: DXCM) has had a rough month. After a Wall Street analyst downgraded the stock Oct. 2 and sharply trimmed its price target, the price fell over the next 30 days, with the majority of the downward movement taking place in the last week of Octo...
Got this from DXCM - Why Is No One Talking About DexCom Stock?
@whytestocks
Recent DXCM News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/15/2026 08:05:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:39:16 PM
- Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day • Business Wire • 05/14/2026 08:02:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 01:47:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:02 PM
- Dexcom to Host Investor Day on May 14, 2026 • Business Wire • 05/05/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 09:20:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:02:43 PM
- Dexcom Reports First Quarter 2026 Financial Results • Business Wire • 04/30/2026 08:02:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 10:24:53 PM
- Why Medtech Giants Are Quietly Paying Up for AI Diagnostics • PR Newswire (Canada) • 04/29/2026 02:30:00 PM
- Why Medtech Giants Are Quietly Paying Up for AI Diagnostics • PR Newswire (US) • 04/29/2026 02:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 11:27:09 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/15/2026 08:13:39 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2026 08:11:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/15/2026 08:06:56 PM
- Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time • Business Wire • 04/02/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:07:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/16/2026 08:02:26 PM
- Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 • Business Wire • 03/11/2026 06:00:00 AM
